• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗初发弥漫性胶质瘤不同分子亚型中 F-FDOPA PET、相对脑血容量和表观扩散系数的体素和患者相关性。

Voxelwise and Patientwise Correlation of F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes.

机构信息

UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California.

Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.

出版信息

J Nucl Med. 2021 Mar;62(3):319-325. doi: 10.2967/jnumed.120.247411. Epub 2020 Jul 9.

DOI:10.2967/jnumed.120.247411
PMID:32646876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8049346/
Abstract

Our purpose was to identify correlations between F-fluorodihydroxyphenylalanine (F-FDOPA) uptake and physiologic MRI, including relative cerebral blood volume (rCBV) and apparent diffusion coefficient (ADC), in gliomas with different molecular subtypes and to evaluate their prognostic values. Sixty-eight treatment-naïve glioma patients who underwent F-FDOPA PET and physiologic MRI were retrospectively selected (36 with isocitrate dehydrogenase wild-type [IDH], 16 with mutant 1p/19q noncodeleted [IDH], and 16 with mutant codeleted [IDH]). Fluid-attenuated inversion recovery hyperintense areas were segmented and used as regions of interest. For voxelwise and patientwise analyses, Pearson correlation coefficients ( and ) between the normalized SUV (nSUV), rCBV, and ADC were evaluated. Cox regression analysis was performed to investigate the associations between overall survival and , maximum or median nSUV, median rCBV, or median ADC. For IDH and IDH gliomas, nSUV demonstrated significant positive correlations with rCBV ( = 0.25 and 0.31, respectively; = 0.50 and 0.70, respectively) and negative correlations with ADC ( = -0.19 and -0.19, respectively; = -0.58 and -0.61, respectively) in both voxelwise and patientwise analyses. IDH gliomas demonstrated a significant positive correlation between nSUV and ADC only in voxelwise analysis ( = 0.18). In Cox regression analysis, between nSUV and rCBV (hazard ratio, 28.82) or ADC (hazard ratio, 0.085) had significant associations with overall survival for only IDH gliomas. IDH gliomas showed distinctive patterns of correlations between amino acid PET and physiologic MRI. Stronger correlations between nSUV and rCBV or ADC may result in a worse prognosis for IDH gliomas.

摘要

我们的目的是确定不同分子亚型胶质瘤中 F-氟代二羟苯丙氨酸(F-FDOPA)摄取与生理 MRI 之间的相关性,包括相对脑血容量(rCBV)和表观扩散系数(ADC),并评估它们的预后价值。回顾性选择了 68 例未经治疗的脑胶质瘤患者,他们接受了 F-FDOPA PET 和生理 MRI 检查(36 例 IDH 野生型,16 例 1p/19q 非缺失型突变 IDH,16 例 IDH 缺失型突变)。对液体衰减反转恢复高信号区域进行分割,并用作感兴趣区。进行体素和患者分析,评估归一化 SUV(nSUV)、rCBV 和 ADC 之间的 Pearson 相关系数(和)。进行 Cox 回归分析以研究总生存期与、最大或中位数 nSUV、中位数 rCBV 或中位数 ADC 之间的相关性。对于 IDH 和 IDH 胶质瘤,nSUV 与 rCBV 呈显著正相关(=0.25 和 0.31,分别;=0.50 和 0.70,分别),与 ADC 呈显著负相关(=-0.19 和-0.19,分别;=-0.58 和-0.61,分别),在体素和患者分析中均如此。仅在体素分析中,IDH 胶质瘤中 nSUV 与 ADC 之间存在显著正相关(=0.18)。在 Cox 回归分析中,nSUV 与 rCBV(危险比,28.82)或 ADC(危险比,0.085)之间的仅在 IDH 胶质瘤中与总生存期存在显著相关性。IDH 胶质瘤中氨基酸 PET 与生理 MRI 之间的相关性存在独特模式。nSUV 与 rCBV 或 ADC 之间的相关性越强,IDH 胶质瘤的预后越差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c9/8049346/406b3d93ab1c/jnm247411absfig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c9/8049346/406b3d93ab1c/jnm247411absfig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c9/8049346/406b3d93ab1c/jnm247411absfig1.jpg

相似文献

1
Voxelwise and Patientwise Correlation of F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes.治疗初发弥漫性胶质瘤不同分子亚型中 F-FDOPA PET、相对脑血容量和表观扩散系数的体素和患者相关性。
J Nucl Med. 2021 Mar;62(3):319-325. doi: 10.2967/jnumed.120.247411. Epub 2020 Jul 9.
2
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.复发性恶性胶质瘤中[18F]FDOPA正电子发射断层显像摄取、表观扩散系数(ADC)与增殖率之间的关系
Mol Imaging Biol. 2015 Jun;17(3):434-42. doi: 10.1007/s11307-014-0807-3.
3
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.18F-FDOPA PET的最大摄取量和高代谢体积评估低级别胶质瘤的分子状态和总生存期:一项PET与MRI研究
Clin Nucl Med. 2020 Dec;45(12):e505-e511. doi: 10.1097/RLU.0000000000003318.
4
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.高级影像学参数可提高弥漫性低级别胶质瘤 IDH 突变型无 1p19q 联合缺失亚型的预测准确性:T2/FLAIR 不匹配征象的附加价值。
Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24.
5
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.多参数 MRI-PET 测量在高代谢区域反映了治疗初发弥漫性胶质瘤中分子状态和肿瘤分级的差异。
J Neurooncol. 2020 Sep;149(2):337-346. doi: 10.1007/s11060-020-03613-6. Epub 2020 Sep 14.
6
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.世界卫生组织II - III级弥漫性胶质瘤组织学和基因亚型中的灌注及扩散磁共振成像特征
J Neurooncol. 2017 Aug;134(1):177-188. doi: 10.1007/s11060-017-2506-9. Epub 2017 May 25.
7
Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.低级别胶质瘤随访中的多参数评估:扩散加权磁共振成像与灌注磁共振成像联合(18)F-多巴正电子发射断层显像的比较
Br J Radiol. 2016 Oct;89(1066):20160476. doi: 10.1259/bjr.20160476. Epub 2016 Aug 9.
8
F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.F-FDOPA PET 和 MRI 特征与肿瘤恶性程度相关,并可预测未经治疗的脑胶质瘤患者的生存情况:一项横断面研究。
J Neurooncol. 2018 Sep;139(2):399-409. doi: 10.1007/s11060-018-2877-6. Epub 2018 Apr 20.
9
Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.利用定量和定性 MRI 特征比较高级别脑胶质瘤的遗传谱和预后:聚焦 G3 级胶质瘤。
Korean J Radiol. 2021 Feb;22(2):233-242. doi: 10.3348/kjr.2020.0011. Epub 2020 Sep 10.
10
Improving Noninvasive Classification of Molecular Subtypes of Adult Gliomas With Diffusion-Weighted MR Imaging: An Externally Validated Machine Learning Algorithm.利用扩散加权磁共振成像提高成人脑胶质瘤分子亚型的无创分类:一种经过外部验证的机器学习算法。
J Magn Reson Imaging. 2023 Oct;58(4):1234-1242. doi: 10.1002/jmri.28630. Epub 2023 Feb 2.

引用本文的文献

1
Effect of Jardiance on glucose uptake into astrocytomas.恩格列净对星形细胞瘤葡萄糖摄取的影响。
J Neurooncol. 2024 Sep;169(2):437-444. doi: 10.1007/s11060-024-04746-8. Epub 2024 Jul 22.
2
Exploring the mechanism of 18F-fluorodopa uptake in recurrent high-grade gliomas: A comprehensive histomolecular-positron emission tomography analysis.探讨复发性高级别胶质瘤中 18F-氟多巴摄取的机制:一项全面的组织分子-正电子发射断层扫描分析。
Eur J Neurol. 2024 Jan;31(1):e16093. doi: 10.1111/ene.16093. Epub 2023 Oct 12.
3
PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area.

本文引用的文献

1
Rate of change in maximum F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas.最大 F-FDOPA PET 摄取率和无增强肿瘤体积的变化率可预测低级别胶质瘤的恶性转化和总生存期。
J Neurooncol. 2020 Mar;147(1):135-145. doi: 10.1007/s11060-020-03407-w. Epub 2020 Jan 24.
2
Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.联合影像检查提高弥漫性胶质瘤浸润的检出率:一项诊断准确性研究。
Neuro Oncol. 2020 Mar 5;22(3):412-422. doi: 10.1093/neuonc/noz180.
3
Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
神经肿瘤学中的正电子发射断层显像(PET)成像:一个快速发展领域的最新进展与概述
Cancers (Basel). 2022 Feb 22;14(5):1103. doi: 10.3390/cancers14051103.
4
Combining F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study.联合 F-DOPA PET 和 MRI 与灌注加权成像可改善治疗前强化和非强化胶质瘤高级亚区的勾画:一项活检对照研究。
J Neurooncol. 2021 Dec;155(3):287-295. doi: 10.1007/s11060-021-03873-w. Epub 2021 Oct 22.
5
Comparison of Amino Acid PET to Advanced and Emerging MRI Techniques for Neurooncology Imaging: A Systematic Review of the Recent Studies.氨基酸 PET 与神经肿瘤学成像的先进和新兴 MRI 技术比较:对近期研究的系统评价。
Mol Imaging. 2021 Jan 20;2021:8874078. doi: 10.1155/2021/8874078. eCollection 2021.
6
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden.伴有较大残余生物肿瘤负荷的 IDH 野生型弥漫性神经胶质瘤预后更差。
Ann Nucl Med. 2021 Sep;35(9):1022-1029. doi: 10.1007/s12149-021-01637-0. Epub 2021 Jun 14.
7
Preferential tumor localization in relation to F-FDOPA uptake for lower-grade gliomas.低级别胶质瘤中 F-FDOPA 摄取与肿瘤优先定位的关系。
J Neurooncol. 2021 May;152(3):573-582. doi: 10.1007/s11060-021-03730-w. Epub 2021 Mar 11.
8
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET.利用机器学习和多参数磁共振/正电子发射断层扫描技术对人脑胶质瘤进行 IDH 状态的鉴别。
Cancer Imaging. 2021 Mar 10;21(1):27. doi: 10.1186/s40644-021-00396-5.
9
Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.神经成像技术的进展以揭示脑肿瘤的生物学和分子特征
Cancers (Basel). 2021 Jan 23;13(3):424. doi: 10.3390/cancers13030424.
10
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.18F-FDOPA PET的最大摄取量和高代谢体积评估低级别胶质瘤的分子状态和总生存期:一项PET与MRI研究
Clin Nucl Med. 2020 Dec;45(12):e505-e511. doi: 10.1097/RLU.0000000000003318.
动态磁敏感对比和扩散磁共振成像根据2016年世界卫生组织脑肿瘤分类确定少突胶质细胞瘤:直方图分析方法
Neuroradiology. 2019 May;61(5):545-555. doi: 10.1007/s00234-019-02173-5. Epub 2019 Feb 2.
4
The mean striatal F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma.纹状体F-DOPA摄取均值并非用于定义胶质瘤生物学肿瘤体积的可靠临界阈值。
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1051-1053. doi: 10.1007/s00259-019-4276-4. Epub 2019 Jan 26.
5
Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes.低级别弥漫性神经胶质瘤的微血管特征:研究血管大小成像以区分级别和亚型。
Eur Radiol. 2019 Apr;29(4):1893-1902. doi: 10.1007/s00330-018-5738-y. Epub 2018 Oct 1.
6
Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity.对整块切除的少突胶质细胞瘤的 PET、MRI 和组织学进行分区分析显示肿瘤内存在异质性。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):569-579. doi: 10.1007/s00259-018-4107-z. Epub 2018 Aug 14.
7
C-MET PET/MRI for detection of recurrent glioma.C-MET PET/MRI 用于检测复发性脑胶质瘤。
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):593-601. doi: 10.1007/s00259-017-3916-9. Epub 2017 Dec 28.
8
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.世界卫生组织II - III级弥漫性胶质瘤组织学和基因亚型中的灌注及扩散磁共振成像特征
J Neurooncol. 2017 Aug;134(1):177-188. doi: 10.1007/s11060-017-2506-9. Epub 2017 May 25.
9
Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.未经治疗的胶质瘤患者中,静态和动态FET-PET参数与基于MRI的脑血容量的瘤内空间相关性。
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):392-397. doi: 10.1007/s00259-016-3585-0. Epub 2016 Dec 2.
10
Intratumoral heterogeneity of F-FLT uptake predicts proliferation and survival in patients with newly diagnosed gliomas.F-FLT摄取的瘤内异质性可预测新诊断胶质瘤患者的增殖和生存情况。
Ann Nucl Med. 2017 Jan;31(1):46-52. doi: 10.1007/s12149-016-1129-0. Epub 2016 Sep 29.